Clinical biochemistry · NHS Bands 2–8

Clinical biochemistry interview questions and training for NHS biomedical scientists

Virtual laboratory, AI-assisted decision support, validation workflows, glucose / HbA1c / paraprotein / toxicology depth, with reference to NICE guidance.

Reviewed by Desmond O., HCPC-registered Biomedical Scientist, and the PathologyLabTraining editorial team

AI clinical support
LIMS validation
NICE guidance
Bench simulation

Virtual biochemistry laboratory

Practise the full NHS biochemistry workflow on a 48-workstation virtual bench, from routine clinical chemistry to cardiac markers, endocrinology, mass spectrometry and POCT.

Virtual Biochemistry Laboratory is available to premium subscribers and trial users.

LIMS

Advanced biochemistry results management

LIMS-style interface for validating and authorising biochemistry results with cross-references to other departments and integrated clinical decision support.

Biochemistry Results Management System is available to premium subscribers and trial users.

AI decision support

Clinical support systems

AI-powered clinical decision support for biochemistry result interpretation, validation, and diagnostic assistance.

Clinical Support Systems is available to premium subscribers and trial users.

Diabetes diagnostics

Glucose & HbA1c analysis

HPLC visualisation of glycated haemoglobin and laboratory analysis of glucose for NHS diabetes diagnosis and monitoring.

HbA1c & Glucose Analysis

HPLC visualisation of glycated haemoglobin (HbA1c) and laboratory analysis of blood glucose

Peak Interpretation

  • HbA0: Unglycated adult haemoglobin (main peak)
  • HbA1c: Glycated haemoglobin used for diabetes monitoring
  • HbF: Fetal haemoglobin
  • HbA2: Minor adult haemoglobin component
Monoclonal gammopathies

Paraprotein analysis

Laboratory investigation and interpretation of monoclonal gammopathies in NHS clinical practice, including serum electrophoresis and immunofixation.

Paraprotein Analysis

Laboratory investigation and interpretation of monoclonal gammopathies

Serum Protein Electrophoresis Patterns

Normal Pattern:Well-defined peaks for each protein fraction with proportions within reference ranges. Albumin is the largest fraction, followed by a balanced distribution across the globulin fractions.

Protein Fractions:

Albumin
Alpha-1
Alpha-2
Beta
Gamma
M-spike

Immunofixation Electrophoresis Patterns

PatternDescriptionFrequencyClinical Notes
IgG KappaBand in IgG and Kappa lanesMost common (~60%)Associated with all stages from MGUS to MM
IgA LambdaBand in IgA and Lambda lanes~15%May have more aggressive clinical course
Light Chain OnlyBand in Kappa or Lambda lane only~15-20%Higher risk of renal complications
BiclonalTwo distinct monoclonal bands~5%Two separate clones or a single clone with multiple heavy chains
Non-secretoryNo detectable monoclonal protein~2-3%Diagnosis requires bone marrow biopsy and imaging
Toxicology

Drug abuse analysis

Laboratory approaches to drug testing, detection windows, and result interpretation for clinical and forensic applications.

Drug Abuse Analysis

Laboratory approaches to drug testing, detection windows, and result interpretation

Immunoassay
GC-MS (Gas Chromatography-Mass Spectrometry)
LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry)
HPLC (High Performance Liquid Chromatography)

Immunoassay

Principle

Antibody-based detection of drug antigens

Common Types

EMIT, ELISA, CEDIA, FPIA

Advantages

Rapid, cost-effective, automation-friendly, high throughput

Limitations

Cross-reactivity, variable cutoff thresholds, false positives/negatives

Primary Applications

Initial screening, point-of-care testing

Laboratory Workflow

  1. Specimen collection with proper chain of custody
  2. Initial screening with immunoassay
  3. Presumptive positive results flagged
  4. Confirmatory testing with mass spectrometry
  5. Medical review of confirmed positive results
  6. Result reporting with appropriate interpretive comments

Sample Considerations

  • Urine: Most common matrix, longer detection window, non-invasive
  • Blood: Reflects current impairment, shorter detection window
  • Oral Fluid: Easy collection, reflects recent use, less adulteration
  • Hair: Long detection window (months), segmental analysis possible
  • Sweat: Continuous monitoring via patches, specialised applications
Reference values

Biochemistry data visualisation

Interactive charts and graphs showcasing key biochemical parameters and their clinical significance across NHS reference ranges.

Lipid Profile Assessment

Comparison of normal, borderline, and high lipid values with reference targets

Key Points:

  • High HDL cholesterol is beneficial ("good cholesterol") - target >1.2 mmol/L
  • Non-HDL cholesterol preferred for monitoring (NICE guidance)
  • CVD secondary prevention (NICE NG238): aim for LDL cholesterol of 2.0 mmol/L or less, or non-HDL cholesterol of 2.6 mmol/L or less
Foundations

Biochemistry quick guide

Essential knowledge areas for biochemistry, from foundational concepts to specialised techniques.

Analytical Techniques

Spectrophotometry, chromatography, mass spectrometry, and automated analyser operations.

Clinical Biochemistry

Liver function, renal profile, cardiac markers, lipids, electrolytes, and acid-base balance.

Endocrinology

Hormone assays, dynamic function tests, thyroid and reproductive hormones, and diabetes markers.

Specialised Testing

Therapeutic drug monitoring, toxicology, trace elements, and metabolic disorders.

Quality Management

Internal quality control, external quality assessment, and accreditation requirements.

Advances in Biochemistry

Point-of-care testing, molecular diagnostics, and personalised medicine applications.

Age-Specific Considerations

Paediatric ALP: 150-520 U/L (3-4x adult), eGFR decline ~1 mL/min/year after age 40, pregnancy: lower creatinine/urea.

Critical Values & Alerts

RCPath G158 v2 (May 2026) adult phoned limits: Potassium ≤2.5 or ≥6.5 mmol/L; Sodium ≤120 or ≥160 mmol/L; Calcium (albumin-adjusted) ≤1.5 or ≥3.5 mmol/L; Glucose ≤2.5 or ≥25 mmol/L; Creatinine ≥354 µmol/L. Communication type A is within 2 hours, usually by telephone, with read-back. Troponin is not on this list: its cut-off is the assay’s own sex-specific 99th percentile. Critical (phoned) limits follow RCPath G158 v2 (May 2026), adapted locally by each trust, so the exact figures can differ between laboratories. The values taught here are the G158 adult limits; in post, read your own laboratory handbook and use its list. Troponin and paracetamol have no single G158 number: both are set by local protocol.

Sources and guidance

This hub's content aligns with the UK's professional and regulatory references for the specialty: